Back to news
world

Federal Inquiry Launched into Gender-Affirming Care at New York Health System

Mount Sinai Health System in New York City is under federal scrutiny regarding its gender-affirming care for adolescent patients. A grand jury has issued a subpoena, seeking information about these medical services.

6/20/2026, 4:31:05 PM

The Mount Sinai Health System recently disclosed a federal investigation into its provision of gender-affirming healthcare to young people. This inquiry, initiated by the Trump administration, became public after the New York institution received a grand jury subpoena. According to The New York Times, the subpoena specifically requests documentation pertaining to adolescent patients who have undergone gender-related medical interventions. This development highlights increasing federal attention on healthcare practices for transgender and gender non-conforming youth. The investigation's focus on Mount Sinai, a prominent medical center in New York City known for its comprehensive healthcare services, suggests a broader scrutiny of facilities offering gender-affirming treatments. Such inquiries can raise concerns among patients, providers, and advocacy groups regarding access to care and patient privacy. Gender-affirming care encompasses a range of medical and psychological services designed to support individuals whose gender identity differs from the sex they were assigned at birth. For adolescents, these services might include puberty blockers, hormone therapy, and mental health support, all typically provided under strict medical guidelines and with parental consent. The New York Times reports that the precise scope and intent of the grand jury’s investigation remain unclear. However, the issuance of a federal subpoena indicates a significant level of governmental interest in the records and practices surrounding these sensitive medical procedures. Healthcare providers offering gender-affirming care often adhere to established medical guidelines and ethical standards. Investigations like this can lead to increased legal and administrative burdens on health systems, potentially impacting the delivery of care. The outcomes of such federal probes are closely watched by healthcare professionals, patients, and policymakers across the nation.

Share